| Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis (NCT05363449) | Therapeutics, Inc. | 2022-02-17 |
| A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. (NCT04883593) | Sun Pharmaceutical Industries, Inc. | 2020-09-03 |
| Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet (NCT04265521) | Biocool AB | 2020-03-03 |
| A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis (NCT03897257) | Therapeutics, Inc. | 2019-03-15 |
| A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis (NCT04152226) | DermBiont, Inc. | 2019-02-19 |
| SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS (NCT03999437) | United Laboratories | 2019-01-02 |
| Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis (NCT03676686) | Natumin Pharma AB | 2018-10-01 |
| Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis (NCT03824912) | Encube Ethicals Pvt. Ltd. | 2018-08-23 |
| Non-inferiority Trial of Dapaconazole Versus Ketoconazole (NCT03320486) | Biolab Sanus Farmaceutica | 2017-11-01 |
| Three-Arm Trial of Novel Treatment for Tinea Pedis (NCT03135912) | South End Skin Care | 2017-01-03 |
| Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis (NCT02842021) | Sol-Gel Technologies, Ltd. | 2016-09-01 |
| SB208 for the Treatment of Tinea Pedis (NCT02860052) | Novan, Inc. | 2016-07-19 |
| Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis (NCT02606383) | Biolab Sanus Farmaceutica | 2016-06-01 |
| Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis (NCT03129321) | Mylan Inc. | 2016-03-15 |
| Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris (NCT02767271) | Bausch Health Americas, Inc. | 2015-12-02 |
| BE Study of Naftifine HCL (NCT02633813) | Genzum Life Sciences | 2015-03-01 |
| Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris (NCT02394340) | Bausch & Lomb Incorporated | 2015-02-03 |
| Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis (NCT02824926) | Gilberto De Nucci | 2014-07-01 |
| Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis (NCT02335255) | Sun Pharmaceutical Industries, Inc. | 2014-06-27 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis (NCT01891305) | Viamet | 2013-08-01 |
| Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis (NCT02132260) | Sun Pharmaceutical Industries, Inc. | 2013-08-01 |
| Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis (NCT01712360) | Merz North America, Inc. | 2012-10-01 |
| Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis (NCT01580891) | Sun Pharmaceutical Industries, Inc. | 2012-05-01 |
| Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections (NCT01105013) | Laboratório Teuto Brasileiro S/A | 2012-04-01 |
| Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis (NCT01580878) | Sun Pharmaceutical Industries, Inc. | 2012-01-01 |
| Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (NCT01524432) | Prof. Yuen Chun-Wah | 2012-01-01 |
| Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis (NCT01433107) | Novartis | 2011-08-01 |
| Topical Antifungal Treatment for Tinea Pedis (NCT01396785) | Medicis Global Service Corporation | 2011-07-01 |
| Topical Antifungal Treatment for Tinea Pedis (NCT01396811) | Medicis Global Service Corporation | 2011-07-01 |
| Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis (NCT01358240) | AmDerma | 2011-06-01 |
| Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis (NCT01353976) | AmDerma | 2011-05-01 |
| Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis (NCT01349998) | Tinea Pharmaceuticals | 2011-05-01 |
| Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (NCT01289015) | Merz North America, Inc. | 2011-02-01 |
| Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis (NCT01096472) | Almirall, S.A. | 2010-02-01 |
| Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo (NCT01013909) | Bayer | 2009-12-01 |
| A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis (NCT00893880) | Nitric BioTherapeutics, Inc | 2009-06-01 |
| Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot) (NCT00848666) | Hillel Yaffe Medical Center | 2009-04-01 |
| Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females (NCT00856596) | Jamaica Hospital Medical Center | 2009-03-01 |
| Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot) (NCT00869336) | Tinea Pharmaceuticals | 2009-03-01 |
| Cumulative Irritation Test (NCT00781664) | Pfizer | 2008-10-01 |
| Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis (NCT00750139) | Merz North America, Inc. | 2008-08-01 |
| Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis (NCT00835510) | Sun Pharmaceutical Industries, Inc. | 2008-06-01 |
| A Study of Econazole Foam 1% in Athlete's Foot (NCT00768599) | AmDerma | 2008-03-01 |
| A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) (NCT00509275) | Stiefel, a GSK Company | 2007-07-01 |
| An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot (NCT01110330) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-07-01 |
| Spread of Dermatophytes Among Families (NCT00233493) | University Hospitals Cleveland Medical Center | 2005-03-01 |
| Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis (NCT00804193) | Padagis LLC | 2004-06-01 |
| Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis (NCT00802672) | Padagis LLC | 2003-12-01 |